Total dose of gonadotropins (IU) ‐ PCOS (high‐responders) ‐ Own oocytes ‐ Early phase stumulation protocol ‐ Frozen embryo transfer (micronised progesterone 100 mg/day versus GnRH antagonists) · assisted reproduction technology cycles
1 finding from 1 review
Moderate or severe OHSS ‐ Poor‐responders (MPA 10 mg versus GnRH antagonists) ‐ Own oocytes ‐ Early phase stimulation protocol · assisted reproduction technology cycles
1 finding from 1 review
no estimate extracted
1 study · 1 participants
GRADE not reported
Moderate or severe OHSS ‐ Normoresponders ‐ Donor oocytes ‐ Early phase stimulation protocol ‐ Fresh embryo transfer (MPA 10 mg/day versus GnRH antagonists) · assisted reproduction technology cycles
1 finding from 1 review
Live birth or ongoing pregnancy sensitivity analysis ‐ PCOS (high‐responders) ‐ own oocytes ‐ early phase stimulation protocol ‐ frozen embryo transfer (micronised progesterone 100 mg/day versus GnRH antagonists) · assisted reproduction technology cycles
Summary of findings table ‐ Progestogens showed no clear difference in live birth or ongoing pregnancy sensitivity analysis ‐ PCOS… compared with gnRH antagonists; GRADE not reported.
1 finding from 1 review
Oocyte pick‐up cancellation sensitivity analysis ‐ Normoresponders (MPA 10 mg versus GnRH antagonists) ‐ Donor oocytes ‐ Early phase stimulation protocol ‐ Fresh embryo transfer · assisted reproduction technology cycles
Summary of findings table ‐ Progestogens showed no clear difference in oocyte pick‐up cancellation sensitivity analysis ‐ Normoresponders… compared with gnRH antagonists; GRADE not reported.
1 finding from 1 review
Oocyte pick‐up cancellation sensitivity analysis ‐ Normoresponders (micronised progesterone 200 mg versus GnRH antagonists) ‐ Own oocytes ‐ Early phase stimulation protocol ‐ Fresh embryo transfer · assisted reproduction technology cycles
Summary of findings table ‐ Progestogens showed no clear difference in oocyte pick‐up cancellation sensitivity analysis ‐ Normoresponders… compared with gnRH antagonists; GRADE not reported.
1 finding from 1 review
Oocyte pick‐up cancellation sensitivity analysis ‐ PCOS (high‐responders)(micronised progesterone 100 mg versus GnRH antagonists) ‐ Own oocytes ‐ Early phase stimulation protocol ‐ Frozen embryo transfer · assisted reproduction technology cycles
Summary of findings table ‐ Progestogens showed no clear difference in oocyte pick‐up cancellation sensitivity analysis ‐ PCOS… compared with gnRH antagonists; GRADE not reported.
1 finding from 1 review
Oocyte pick‐up cancellation sensitivity analysis ‐ total · assisted reproduction technology cycles
Summary of findings table ‐ Progestogens showed no clear difference in oocyte pick‐up cancellation sensitivity analysis ‐ total compared with gnRH antagonists; GRADE not reported.
1 finding from 1 review
Clinical pregnancy · assisted reproduction technology cycles
Summary of findings table ‐ Progestogens showed no clear difference in clinical pregnancy ‐ Poor‐responders (MPA 10 mg versus GnRH… compared with gnRH antagonists (low certainty).
1 finding from 1 review
Miscarriage · assisted reproduction technology cycles
1 finding from 1 review
Live birth or ongoing pregnancy ‐ Poor‐responders (MPA 10 mg versus GnRH antagonists) ‐ Own oocytes ‐ Early phase stimulation protocol · assisted reproduction technology cycles
Summary of findings table ‐ Progestogens showed no clear difference in live birth or ongoing pregnancy ‐ Poor‐responders (MPA 10 mg versus… compared with gnRH antagonists; GRADE not reported.
1 finding from 1 review
Cumulative pregnancy rate · assisted reproduction technology cycles
1 finding from 1 review
no estimate extracted
1 study · 1 participants
GRADE not reported
Premature LH surge ‐ Donor oocytes ‐ Normoresponders ‐ Early phase stimulation protocol ‐ Fresh embryo transfer · assisted reproduction technology cycles
1 finding from 1 review
no estimate extracted
1 study · 1 participants
GRADE not reported
Stopping breastfeeding (any) at 6 months · healthy breastfeeding women with healthy term babies
Summary of findings table ‐ Support plus probably leads to lower stopping breastfeeding (any) at 6 months compared with usual care (moderate certainty).
1 finding from 1 review
Stopping exclusive breastfeeding at 6 months · healthy breastfeeding women with healthy term babies
Summary of findings table ‐ Support plus may leads to lower stopping exclusive breastfeeding at 6 months compared with usual care (low certainty).
1 finding from 1 review
Stopping breastfeeding (any) at 4‐6 weeks · healthy breastfeeding women with healthy term babies
Summary of findings table ‐ Support plus showed no clear difference in stopping breastfeeding (any) at 4‐6 weeks compared with usual care (moderate certainty).
1 finding from 1 review
Stopping exclusive breastfeeding at 4‐6 weeks · healthy breastfeeding women with healthy term babies
It is very uncertain whether summary of findings table ‐ Support plus changes stopping exclusive breastfeeding at 4‐6 weeks compared with usual care (very low certainty).
1 finding from 1 review
Stopping breastfeeding (any) at 2 months · healthy breastfeeding women with healthy term babies
Summary of findings table ‐ Support plus showed no clear difference in stopping breastfeeding (any) at 2 months compared with usual care (moderate certainty).
1 finding from 1 review
Stopping exclusive breastfeeding at 2 months · healthy breastfeeding women with healthy term babies
It is very uncertain whether summary of findings table ‐ Support plus changes stopping exclusive breastfeeding at 2 months compared with usual care (very low certainty).
2 findings from 1 review
Stopping breastfeeding (any) at 3‐4 months · healthy breastfeeding women with healthy term babies
Summary of findings table ‐ Support plus showed no clear difference in stopping breastfeeding (any) at 3‐4 months compared with usual care (low certainty).
1 finding from 1 review